Trials / Unknown
UnknownNCT05810324
18F-FAPI PET/CT in Patients With Various Types of Cancer
The Performance of 18F-FAPI PET/CT in Patients With Various Types of Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 500 (estimated)
- Sponsor
- Jilin University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the potential usefulness of 18F-FAPI positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various types of cancer.
Detailed description
Subjects with various types of cancer underwent 18F-FAPI PET/CT either for an initial assessment or for recurrence detection. Tumor uptake was quantified by the maximum standard uptake value (SUVmax). Using histopathology and follow-up as gold standard, the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of 18F-FAPI PET/CT were calculated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 18F-FAPI | Each patient receive a single intravenous injection of 18F-FAPI, and undergo PET/CT scan within specified time. |
Timeline
- Start date
- 2022-07-01
- Primary completion
- 2024-07-01
- Completion
- 2025-01-01
- First posted
- 2023-04-12
- Last updated
- 2023-04-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05810324. Inclusion in this directory is not an endorsement.